肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2009年
1期
35-37
,共3页
邵淑丽%闫丽隽%蔡昱%王全红
邵淑麗%閆麗雋%蔡昱%王全紅
소숙려%염려준%채욱%왕전홍
葡萄糖转运蛋白类,易化性%卵巢肿瘤%肿瘤,囊性,黏液性和浆液性
葡萄糖轉運蛋白類,易化性%卵巢腫瘤%腫瘤,囊性,黏液性和漿液性
포도당전운단백류,역화성%란소종류%종류,낭성,점액성화장액성
Glucose transport proteins,facilitative%Ovarian neoplasms%Neoplasms,cystic,mucinous and serous
目的 探讨葡萄糖转运蛋白1(GLUT-1)在卵巢浆液性肿瘤中的表达及其意义.方法 收集100例卵巢浆液性肿瘤患者手术标本,采用多克隆抗体的GLUT-1免疫组织化学SP法进行染色,分析其异常表达与肿瘤临床分期及分型之间的相关性.结果 正常组织中GLUT-1表达为阴性,GLUT-1在良性、交界性、恶性卵巢浆液性肿瘤中的表达呈增高趋势(P<0.001),GLUT-1的表达与卵巢浆液性囊腺癌临床分期呈正相关(P<0.001).结论 GLUT-1的过度表达与卵巢浆液性肿瘤的组织学和分期相关.GLUT-1有望成为检测卵巢浆液性肿瘤恶变的标志物.
目的 探討葡萄糖轉運蛋白1(GLUT-1)在卵巢漿液性腫瘤中的錶達及其意義.方法 收集100例卵巢漿液性腫瘤患者手術標本,採用多剋隆抗體的GLUT-1免疫組織化學SP法進行染色,分析其異常錶達與腫瘤臨床分期及分型之間的相關性.結果 正常組織中GLUT-1錶達為陰性,GLUT-1在良性、交界性、噁性卵巢漿液性腫瘤中的錶達呈增高趨勢(P<0.001),GLUT-1的錶達與卵巢漿液性囊腺癌臨床分期呈正相關(P<0.001).結論 GLUT-1的過度錶達與卵巢漿液性腫瘤的組織學和分期相關.GLUT-1有望成為檢測卵巢漿液性腫瘤噁變的標誌物.
목적 탐토포도당전운단백1(GLUT-1)재란소장액성종류중적표체급기의의.방법 수집100례란소장액성종류환자수술표본,채용다극륭항체적GLUT-1면역조직화학SP법진행염색,분석기이상표체여종류림상분기급분형지간적상관성.결과 정상조직중GLUT-1표체위음성,GLUT-1재량성、교계성、악성란소장액성종류중적표체정증고추세(P<0.001),GLUT-1적표체여란소장액성낭선암림상분기정정상관(P<0.001).결론 GLUT-1적과도표체여란소장액성종류적조직학화분기상관.GLUT-1유망성위검측란소장액성종류악변적표지물.
Objective To evaluate the expression of the GLUT-1 glucose transporter in borderline and malignant epithelial neoplasms of the ovary. Methods Histologic sections of tumor tissues from 100 epithelial neoplasms of the ovary were stained for GLUT-1 using polyclonal GLUT-1 antibody and the labeled streptavidin procedure. Chi-square analysis was used to assess if their expression was associated with clinicopathoiogic characteristics of the tumors. Results Normal ovarian surface epithelial cell were either negative or weakly positive. The intensity of the stain was significantly stronger in malignant than borderline tumors (P<0.001). In malignant neoplasms, the intensity of the stain for GLUT-1 increased with histology. Conclusion Overexpression of the GLUT-1 transporter is associated with the histology and grade of the minors. These data suggest that the expression of this transporter may be closely related to the malignant transformation of epithelial ovarian tumors.